PHYSIOLOGICALLY-BASED TOXICOKINETIC MODELING OF 1,3-BUTADIENE LUNG METABOLISM IN MICE BECOMES MORE IMPORTANT AT LOW-DOSES

被引:23
作者
EVELO, CTA
OOSTENDORP, JGM
TENBERGE, WF
BORM, PJA
机构
[1] DSM,CORP DIV SAFETY & ENVIRONM,HEERLEN,NETHERLANDS
[2] UNIV LIMBURG,DEPT HLTH RISK ANAL & TOXICOL,6200 MD MAASTRICHT,NETHERLANDS
关键词
1,3-BUTADIENE; COMPUTER SIMULATION; PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING; PHYSIOLOGICALLY BASED TOXICOKINETIC MODELING; RISK EVALUATION; TOXICOKINETICS;
D O I
10.2307/3431586
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
This paper describes a physiologically based toxicokinetic model for 1,3-butadiene uptake, distribution, and metabolic clearance in mice. Model parameters for metabolic activity were estimated from the correspondence between computer simulation studies and experimental results as published in the literature. The parameterized model was validated with independent literature data. With the resulting model, the relative importance of lung metabolism as compared to metabolism in the liver increased with decreasing ambient air concentrations. This was due to saturation of metabolism in the alveolar area of the lung, which occurred in the simulations at ambient air concentrations well below current threshold limit values. At higher air concentration, liver metabolism became relatively more important. The tendency toward increased importance of lung metabolism at low doses indicates the necessity of careful extrapolation of in vive results to low doses. Moreover, this trend may also contribute to species difference in susceptibility to the carcinogenic activity of butadiene.
引用
收藏
页码:496 / 502
页数:7
相关论文
共 39 条
[1]   PHYSIOLOGICALLY BASED PHARMACOKINETICS AND THE RISK ASSESSMENT PROCESS FOR METHYLENE-CHLORIDE [J].
ANDERSEN, ME ;
CLEWELL, HJ ;
GARGAS, ML ;
SMITH, FA ;
REITZ, RH .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 87 (02) :185-205
[2]  
BOERS JM, 1988, PUBLICATION DUTCH S, V49
[3]   INHALATION PHARMACOKINETICS BASED ON GAS UPTAKE STUDIES .5. COMPARATIVE PHARMACOKINETICS OF ETHYLENE AND 1,3-BUTADIENE IN RATS [J].
BOLT, HM ;
FILSER, JG ;
STORMER, F .
ARCHIVES OF TOXICOLOGY, 1984, 55 (04) :213-218
[4]   BIOLOGICAL ACTIVATION OF 1,3-BUTADIENE TO VINYL OXIRANE BY RAT-LIVER MICROSOMES AND EXPIRATION OF THE REACTIVE METABOLITE BY EXPOSED RATS [J].
BOLT, HM ;
SCHMIEDEL, G ;
FILSER, JG ;
ROLZHAUSER, HP ;
LIESER, K ;
WISTUBA, D ;
SCHURIG, V .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1983, 106 (02) :112-116
[5]   METABOLISM OF 1,3-BUTADIENE BY LUNG AND LIVER-MICROSOMES OF RATS AND MICE REPEATEDLY EXPOSED BY INHALATION TO 1,3-BUTADIENE [J].
BOND, JA ;
MARTIN, OS ;
BIRNBAUM, LS ;
DAHL, AR ;
MELNICK, RL ;
HENDERSON, RF .
TOXICOLOGY LETTERS, 1988, 44 (1-2) :143-151
[6]   ANALYSIS OF 1,3-BUTADIENE AND OTHER SELECTED GAS-PHASE COMPONENTS IN CIGARETTE MAINSTREAM AND SIDESTREAM SMOKE BY GAS-CHROMATOGRAPHY MASS SELECTIVE DETECTION [J].
BRUNNEMANN, KD ;
KAGAN, MR ;
COX, JE ;
HOFFMANN, D .
CARCINOGENESIS, 1990, 11 (10) :1863-1868
[7]  
CARPENTER C. P., 1944, Journal of Industrial Hygiene and Toxicology, V26, P69
[8]   COMPARISON OF THE BIOTRANSFORMATION OF 1,3-BUTADIENE AND ITS METABOLITE, BUTADIENE MONOEPOXIDE, BY HEPATIC AND PULMONARY TISSUES FROM HUMANS, RATS AND MICE [J].
CSANADY, GA ;
GUENGERICH, FP ;
BOND, JA .
CARCINOGENESIS, 1992, 13 (07) :1143-1153
[9]   SPECIES-DIFFERENCES IN THE METABOLISM AND DISPOSITION OF INHALED 1,3-BUTADIENE AND ISOPRENE [J].
DAHL, AR ;
BECHTOLD, WE ;
BOND, JA ;
HENDERSON, RF ;
MAUDERLY, JL ;
MUGGENBURG, BA ;
SUN, JD ;
BIRNBAUM, LS .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1990, 86 :65-69
[10]   TOXICOKINETICS OF INHALED 1,3-BUTADIENE IN MONKEYS - COMPARISON TO TOXICOKINETICS IN RATS AND MICE [J].
DAHL, AR ;
SUN, JD ;
BIRNBAUM, LS ;
BOND, JA ;
GRIFFITH, WC ;
MAUDERLY, JL ;
MUGGENBURG, BA ;
SABOURIN, PJ ;
HENDERSON, RF .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 110 (01) :9-19